Literature DB >> 2435424

Antibodies to glycolipids in demyelinating diseases of the human peripheral nervous system.

R H Quarles, A A Ilyas, H J Willison.   

Abstract

Antibodies to complex glycolipids occur in patients with a variety of diseases of the peripheral nervous system. Many patients with demyelinating neuropathy occurring in association with IgM paraproteinemia have a monoclonal antibody that reacts with a carbohydrate determinant shared between sulfate-3-glucuronyl paragloboside (SGPG), the myelin-associated glycoprotein and other glycoproteins of peripheral nerve. Other patients with neuropathy in association with IgM paraproteinemia have monoclonal antibodies reacting with carbohydrate determinants on various gangliosides. More than 80% of the IgM monoclonal antibodies from patients of this type that have been screened in our laboratory react with SGPG or ganglioside antigens. High levels of antibodies reacting with ganglioside antigens are also found in some patients with inflammatory neuropathies such as Guillain-Barré Syndrome and chronic relapsing inflammatory polyneuropathy. The pathogenetic significance of these antibodies reacting with acidic sphingoglycolipids remains to be established.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2435424     DOI: 10.1016/0009-3084(86)90055-1

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  23 in total

Review 1.  Relationship between autoantibody specificities and peripheral nervous system involvements.

Authors:  M O Jauberteau-Marchan
Journal:  Clin Rev Allergy Immunol       Date:  2000-08       Impact factor: 8.667

2.  Ataxic polyneuropathy and anti-Pr2 IgM kappa M proteinemia.

Authors:  M Arai; H Yoshino; Y Kusano; Y Yazaki; Y Ohnishi; T Miyatake
Journal:  J Neurol       Date:  1992-03       Impact factor: 4.849

Review 3.  Autoimmune responses in peripheral nerve.

Authors:  H P Hartung; H Willison; S Jung; M Pette; K V Toyka; G Giegerich
Journal:  Springer Semin Immunopathol       Date:  1996

Review 4.  Antiglycolipid antibodies in peripheral neuropathy: fact or fiction?

Authors:  H J Willison
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

5.  Peripheral neuropathy associated with monoclonal IgM antibody to glycolipids with a terminal glucuronyl-3-sulfate epitope.

Authors:  P Fredman; J Lycke; O Andersen; M Vrethem; J Ernerudh; L Svennerholm
Journal:  J Neurol       Date:  1993-06       Impact factor: 4.849

Review 6.  Expression and biological functions of sulfoglucuronyl glycolipids (SGGLs) in the nervous system--a review.

Authors:  F B Jungalwala
Journal:  Neurochem Res       Date:  1994-08       Impact factor: 3.996

7.  Peripheral neuropathy associated with monoclonal IgM anti-Pr2 cold agglutinins.

Authors:  H J Willison; G Paterson; J Veitch; G Inglis; S C Barnett
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-11       Impact factor: 10.154

8.  Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside.

Authors:  H J Willison; J Veitch; G Paterson; P G Kennedy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-02       Impact factor: 10.154

9.  Acute motor neuropathy with antibodies to GM1 ganglioside.

Authors:  N A Gregson; D Jones; P K Thomas; H J Willison
Journal:  J Neurol       Date:  1991-12       Impact factor: 4.849

10.  Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin.

Authors:  P Fredman; C A Vedeler; H Nyland; J A Aarli; L Svennerholm
Journal:  J Neurol       Date:  1991-04       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.